Table 5 Molecular subtype by stage of the disease in the studied patients.
Stage | No. | Molecular subtype | p-value | |||||
|---|---|---|---|---|---|---|---|---|
Luminal A | Luminal B | Luminal B - HER2+ | Low HER2 overexpression | High HER2 overexpression | Triple-negative | |||
No. (%) | ||||||||
No lesion | 13 | 1.0 (7.7) | 0.0 (0.0) | 8.0(61.5) | 1.0 (7.7) | 2.0 (15.4) | 1.0 (7.7) | < 0.001* |
I A | 65 | 19 (29.2) | 28 (43.1) | 11 (16.9) | 0.0 (0.0) | 3.0 (4.6) | 4.0 (6.2) | |
II A | 91 | 22 (24.2) | 38 (41.8) | 18 (19.8) | 0.0 (0.0) | 1.0 (1.1) | 12(13.2) | |
II B | 52 | 17 (32.7) | 17 (32.7) | 13 (25.0) | 0.0 (0.0) | 1.0 (1.9) | 4.0 (7.7) | |
III A | 32 | 13 (40.6) | 14 (43.7) | 2.0 (6.3) | 0.0 (0.0) | 2.0 (6.3) | 1.0 (3.1) | |
III C | 47 | 9.0(19.1) | 20 (42.6) | 17 (36.2) | 0.0 (0.0) | 0.0 (0.0) | 1.0 (2.1) | |
Total | 300 | 81 (27.0) | 117(39.0) | 69 (23.0) | 1.0 (0.3) | 9.0 (3.0) | 23 (7.7) | |
